Transcatheter embolization devices market seen reaching $8.33 billion by 2030

The Business Research Company projects the global transcatheter embolization and occlusion devices market will grow from $5.79 billion in 2026 to $8.33 billion by 2030, powered by demand for minimally invasive and image-guided treatments. North America led the market in 2025, while rising use in neurointerventional and oncology procedures is expected to keep growth strong.

Why it matters: - Transcatheter embolization and occlusion devices are used to block blood flow in targeted areas through minimally invasive procedures. - The devices support treatment of vascular malformations, tumors and other conditions where precise blood-flow control matters. - The market outlook points to continued demand for less invasive interventions, image guidance and specialized embolic materials.

What happened: - The Business Research Company published a market study on transcatheter embolization and occlusion devices on Sept. 1, 2026. - The report projects the market will rise from $5.23 billion in 2025 to $5.79 billion in 2026, a 10.6% CAGR. - The same study forecasts the market will reach $8.33 billion by 2030, expanding at a 9.5% CAGR. - Download a free sample of the report. - Read the full market report.

The details: - The report cites growth drivers including wider use of interventional radiology, higher prevalence of vascular disease, broader access to catheter-based treatments and better imaging guidance. - The study says future growth will also be supported by demand for targeted embolization therapies, more sophisticated embolic materials and growing use in neurointerventional and oncology procedures. - Investment in interventional healthcare infrastructure is identified as another growth factor. - Expected trends include wider adoption of minimally invasive embolization methods, more use of advanced liquid embolic agents, greater reliance on detachable and coated coils, expanded image-guided interventions and development of precision occlusion technologies. - The report describes transcatheter embolization and occlusion devices as catheter-delivered tools that block blood flow to specific parts of the body while minimizing damage to surrounding tissue. - The devices are used in procedures that can manage vascular malformations and tumors. - North America remained the dominant regional market in 2025. - The analysis also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast reflects a broader shift in medicine toward procedures that reduce recovery time, pain and complications. - The mention of robotic surgery growth from Intuitive Surgical underscores how minimally invasive care is expanding across specialties, not just in embolization. - The report’s emphasis on precision medicine suggests device makers are competing on more targeted and image-guided treatment options. - The new report format includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.

What's next: - The market is expected to keep growing through 2030 as hospitals and procedural specialists expand use of image-guided and catheter-based therapies. - Adoption should rise for liquid embolics, detachable coils and other precision occlusion tools as clinical use cases broaden. - Regional growth beyond North America will likely depend on infrastructure investment and access to advanced interventional care.